» Articles » PMID: 21051230

Synthesis and Pharmacological Evaluation of the Stereoisomers of 3-carba Cyclic-phosphatidic Acid

Abstract

Cyclic phosphatidic acid (CPA) is a naturally occurring analog of lysophosphatidic acid (LPA) in which the sn-2 hydroxy group forms a five-membered ring with the sn-3 phosphate. Here, we describe the synthesis of R-3-CCPA and S-3-CCPA along with their pharmacological properties as inhibitors of lysophospholipase D/autotaxin, agonists of the LPA(5) GPCR, and blockers of lung metastasis of B16-F10 melanoma cells in a C57BL/6 mouse model. S-3CCPA was significantly more efficacious in the activation of LPA(5) compared to the R-stereoisomer. In contrast, no stereoselective differences were found between the two isomers toward the inhibition of autotaxin or lung metastasis of B16-F10 melanoma cells in vivo. These results extend the potential utility of these compounds as potential lead compounds warranting evaluation as cancer therapeutics.

Citing Articles

Efficient Synthesis of Novel Phostone and Phostam Derivatives Regioselective Intramolecular Heck Cyclizations of (2-Iodobenzyl)buta-1,3-dienylphosphonates, (2-Iodophenyl)buta-1,3-dienylphosphonates, and....

Sanaa H, Touil S, Durandetti M, Samarat A ACS Omega. 2024; 9(44):44542-44548.

PMID: 39524664 PMC: 11541441. DOI: 10.1021/acsomega.4c06616.


Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.

Liu T, Yin D, Wang N, Li N, Dong G, Peng M Front Endocrinol (Lausanne). 2023; 14:1140094.

PMID: 37324256 PMC: 10266228. DOI: 10.3389/fendo.2023.1140094.


Design and Development of Autotaxin Inhibitors.

Jia Y, Li Y, Xu X, Tian Y, Shang H Pharmaceuticals (Basel). 2021; 14(11).

PMID: 34832985 PMC: 8622848. DOI: 10.3390/ph14111203.


Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma.

Murph M, Jiang G, Altman M, Jia W, Nguyen D, Fambrough J Bioorg Med Chem. 2015; 23(17):5999-6013.

PMID: 26190462 PMC: 4554797. DOI: 10.1016/j.bmc.2015.06.054.


Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface.

Fells J, Lee S, Fujiwara Y, Norman D, Lim K, Tsukahara R Mol Pharmacol. 2013; 84(3):415-24.

PMID: 23793291 PMC: 3876816. DOI: 10.1124/mol.113.087080.


References
1.
Masuda A, Nakamura K, Izutsu K, Igarashi K, Ohkawa R, Jona M . Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol. 2008; 143(1):60-70. DOI: 10.1111/j.1365-2141.2008.07325.x. View

2.
Kehlen A, Englert N, Seifert A, Klonisch T, Dralle H, Langner J . Expression, regulation and function of autotaxin in thyroid carcinomas. Int J Cancer. 2004; 109(6):833-8. DOI: 10.1002/ijc.20022. View

3.
Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, Kitayama J . Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem. 2006; 281(25):17492-17500. DOI: 10.1074/jbc.M601803200. View

4.
Durgam G, Virag T, Walker M, Tsukahara R, Yasuda S, Liliom K . Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin. J Med Chem. 2005; 48(15):4919-30. DOI: 10.1021/jm049609r. View

5.
Murakami-Murofushi K, Uchiyama A, Fujiwara Y, Kobayashi T, Kobayashi S, Mukai M . Biological functions of a novel lipid mediator, cyclic phosphatidic acid. Biochim Biophys Acta. 2002; 1582(1-3):1-7. DOI: 10.1016/s1388-1981(02)00131-2. View